hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
volume declines in cement , some agricultural products , and newsprint shipments partially offset the increases . operating expenses millions of dollars 2008 2007 2006 % (  % ) change 2008 v 2007 % (  % ) change 2007 v 2006 .

Table:
millions of dollars | 2008 | 2007 | 2006 | % (  % ) change 2008 v 2007 | % (  % ) change 2007 v 2006
compensation and benefits | $ 4457 | $ 4526 | $ 4535 | ( 2 ) % (  % ) | -% ( - % )
fuel | 3983 | 3104 | 2968 | 28 | 5
purchased services and materials | 1902 | 1856 | 1756 | 2 | 6
depreciation | 1387 | 1321 | 1237 | 5 | 7
equipment and other rents | 1326 | 1368 | 1396 | -3 ( 3 ) | -2 ( 2 )
other | 840 | 733 | 802 | 15 | -9 ( 9 )
total | $ 13895 | $ 12908 | $ 12694 | 8 % (  % ) | 2% ( 2 % )
operating expenses increased $ 987 million in 2008 .
our fuel price per gallon rose 39% ( 39 % ) during the year , increasing operating expenses by $ 1.1 billion compared to 2007 .
wage , benefit , and materials inflation , higher depreciation , and costs associated with the january cascade mudslide and hurricanes gustav and ike also increased expenses during the year .
cost savings from productivity improvements , better resource utilization , and lower volume helped offset these increases .
operating expenses increased $ 214 million in 2007 versus 2006 .
higher fuel prices , which rose 9% ( 9 % ) during the period , increased operating expenses by $ 242 million .
wage , benefit and materials inflation and higher depreciation expense also increased expenses during the year .
productivity improvements , better resource utilization , and a lower fuel consumption rate helped offset these increases .
compensation and benefits 2013 compensation and benefits include wages , payroll taxes , health and welfare costs , pension costs , other postretirement benefits , and incentive costs .
productivity initiatives in all areas , combined with lower volume , led to a 4% ( 4 % ) decline in our workforce for 2008 , saving $ 227 million compared to 2007 .
conversely , general wage and benefit inflation and higher pension and postretirement benefits increased expenses in 2008 , partially offsetting these reductions .
operational improvements and lower volume levels in 2007 led to a 1% ( 1 % ) decline in our workforce , saving $ 79 million in 2007 compared to 2006 .
a smaller workforce and less need for new train personnel reduced training costs during the year , which contributed to the improvement .
general wage and benefit inflation mostly offset the reductions , reflecting higher salaries and wages and the impact of higher healthcare and other benefit costs .
fuel 2013 fuel includes locomotive fuel and gasoline for highway and non-highway vehicles and heavy equipment .
diesel fuel prices , which averaged $ 3.15 per gallon ( including taxes and transportation costs ) in 2008 compared to $ 2.27 per gallon in 2007 , increased expenses by $ 1.1 billion .
a 4% ( 4 % ) improvement in our fuel consumption rate resulted in $ 136 million of cost savings due to the use of newer , more fuel 2008 operating expenses .

Question: what percent of total operating expenses was fuel in 2008?
Answer: 29%
Calculation: divide(3983, 13895)
The average duration of the defined benefit obligation at the end of the reporting period is 6.8 years (2018: 6.3 years) which relates wholly to active participants.
The plan invests entirely in pooled superannuation trust products where prices are quoted daily. The asset allocation of the plan has been set taking into account the membership profile, the liquidity requirements of the plan, and risk appetite of the Group.
The percentage invested in each asset class is as follows:
Table:
 | 2019 | 2018
 | % | %
Equity instruments | 53.9 | 58.5
Debt instruments | 18.6 | 22.5
Real estate | 10.8 | 3.5
Cash and cash equivalents | 3.7 | 3.0
Other | 13.0 | 12.5
Total | 100.0 | 100.0


Question: What does the plan invests in?
Answer: pooled superannuation trust products where prices are quoted daily.
In 2019, Global Financing delivered external revenue of $1,400 million and total revenue of $2,632 million, with a decrease in gross margin of 2.7 points to 58.8 percent. Total pre-tax income of $1,055 million decreased 22.5 percent compared to 2018 and return on equity decreased 5.0 points to 25.8 percent.
Global Financing total revenue decreased 17.8 percent compared to the prior year. This was due to a decrease in internal revenue of 23.5 percent, driven by decreases in internal used equipment sales (down 27.4 percent to $862 million) and internal financing (down 12.6 percent to $370 million). External revenue declined 11.9 percent due to decreases in external financing (down 8.5 percent to $1,120 million) and external used equipment sales (down 23.4 percent to $281 million).
The decrease in internal financing revenue was due to lower average asset balances, partially offset by higher asset yields. The decrease in external financing revenue reflects the wind down of the OEM IT commercial financing operations.
Sales of used equipment represented 43.4 percent and 48.5 percent of Global Financing’s revenue for the years ended December 31, 2019 and 2018, respectively. The decrease in 2019 was due to a lower volume of internal used equipment sales. The gross profit margin on used sales was 52.2 percent and 54.2 percent for the years ended December 31, 2019 and 2018, respectively. The decrease in the gross profit margin was driven by lower margins on internal used equipment sales.
Global Financing pre-tax income decreased 22.5 percent year to year primarily driven by a decrease in gross profit ($422 million), partially offset by a decrease in total expense ($115 million), which was mainly driven by a decline in IBM shared expenses in line with the segment’s performance, a lower provision for credit losses and a gain from the sale of certain commercial financing capabilities in the first quarter of 2019.
The decrease in return on equity from 2018 to 2019 was primarily due to lower net income. Refer to page 45 for the details of the after-tax income and return on equity calculations.
Table:
($ in millions) |  |  | 
For the year ended December 31: | 2019 | 2018 | Yr.-to-Yr. Percent Change
External revenue | $1,400 | $1,590 | (11.9) %
Internal revenue | 1,232 | 1,610 | (23.5)
Total revenue | $2,632 | $3,200 | (17.8) %
Pre-tax income | $1,055 | $1,361 | (22.5) %


Question: What is the increase / (decrease) in the internal revenue from 2018 to 2019?
Answer: -378
Calculation: 1,232 - 1,610
ALTERNATIVE PERFORMANCE MEASURES – continued
Return on Invested Capital (RoIC): TORM defines RoIC as earnings before interest and tax (EBIT) less tax, divided by the average invested capital for the period. Invested capital is defined below.
RoIC expresses the returns generated on capital invested in the Group. The progression of RoIC is used by TORM to measure progress against our longer-term value creation goals outlined to investors. RoIC is calculated as follows:
Table:
USDm | 2019 | 2018 | 2017
Operating profit/(loss) (EBIT) | 205.9 | 2.8 | 39.5
Tax | -0.8 | -1.6 | -0.8
EBIT less Tax | 205.1 | 1.2 | 38.7
Invested capital, opening balance | 1,469.4 | 1,406.0 | 1,387.7
Invested capital, ending balance | 1,786.0 | 1,469.4 | 1,406.0
Average invested capital for the year | 1,627.7 | 1,437.7 | 1,396.9
Return on Invested Capital (RoIC) | 12.6% | 0.1% | 2.8%


Question: What are the components in the table which is used to directly derive the RoIC?
Answer: EBIT less Tax, Average invested capital for the year
Note 13. Basic and Diluted Net Loss Per Share
Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, less the weighted-average unvested common stock subject to repurchase or forfeiture as they are not deemed to be issued for accounting purposes. Diluted net loss per share is computed by giving effect to all potential shares of common stock, stock options, restricted stock units, ESPP, and convertible senior notes, to the extent dilutive. For the periods presented, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive.
The following table sets forth the computation of the Company’s basic and diluted net loss per share during the years ended December 31, 2019, 2018 and 2017 (in thousands, except per share data)
Table:
 |  | Year Ended December 31, | 
 | 2019 | 2018 | 2017
Numerator |  |  | 
Net loss | $(53,607) | $(26,203) | $(4,204)
Denominator |  |  | 
Weighted-average common shares for basic and diluted net loss per share | 83,130 | 79,500 | 76,281
Basic and diluted net loss per share | $(0.64) | $(0.33) | $(0.06)


Question: What are the respective basic and diluted net loss per share in 2017 and 2018?
Answer: (0.06), (0.33)
abiomed , inc . and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 3 . acquisitions ( continued ) including the revenues of third-party licensees , or ( ii ) the company 2019s sale of ( a ) ecp , ( b ) all or substantially all of ecp 2019s assets , or ( c ) certain of ecp 2019s patent rights , the company will pay to syscore the lesser of ( x ) one-half of the profits earned from such sale described in the foregoing item ( ii ) , after accounting for the costs of acquiring and operating ecp , or ( y ) $ 15.0 million ( less any previous milestone payment ) . ecp 2019s acquisition of ais gmbh aachen innovative solutions in connection with the company 2019s acquisition of ecp , ecp acquired all of the share capital of ais gmbh aachen innovative solutions ( 201cais 201d ) , a limited liability company incorporated in germany , pursuant to a share purchase agreement dated as of june 30 , 2014 , by and among ecp and ais 2019s four individual shareholders . ais , based in aachen , germany , holds certain intellectual property useful to ecp 2019s business , and , prior to being acquired by ecp , had licensed such intellectual property to ecp . the purchase price for the acquisition of ais 2019s share capital was approximately $ 2.8 million in cash , which was provided by the company , and the acquisition closed immediately prior to abiomed europe 2019s acquisition of ecp . the share purchase agreement contains representations , warranties and closing conditions customary for transactions of its size and nature . purchase price allocation the acquisition of ecp and ais was accounted for as a business combination . the purchase price for the acquisition has been allocated to the assets acquired and liabilities assumed based on their estimated fair values . the acquisition-date fair value of the consideration transferred is as follows : acquisition date fair value ( in thousands ) .

Table:
 | total acquisition date fair value ( in thousands )
cash consideration | $ 15750
contingent consideration | 6000
total consideration transferred | $ 21750
.

Question: for the ecp and ais transactions , what portion of the total consideration was paid immediately in cash?
Answer: 72.4%
Calculation: divide(15750, 21750)
Equity Incentive Plan
Our board of directors administers the plan, determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients. The stock options granted under the plan have terms of up to 10 years. As of December 31, 2019, awards for the purchase of 4,236,719 shares have been granted and remain outstanding (common stock options, common stock and restricted stock units) and 2,063,281 shares are reserved for future grants under the 2014 Plan.
Share-based compensation expenses related to stock options, stock and restricted stock units issued to employees and directors are included in selling, general and administrative expenses. The following table provides a detail of share-based compensation expense (in thousands).
Table:
Year Ended December 31 |  | 
 | 2019 | 2018
Common stock, vested at issuance and nonvested at issuance | $721 | $555
Stock options | 354 | 132
Restricted stock units | 225 | 103
Compensation expense related to common stock awards issued under equity incentive plan | $          1,300 | $            790


Question: What is the total value of stock options in 2018 and 2019?
Answer: 486
Calculation: 354 + 132
Sales and Marketing
Sales and marketing expenses increased $3.1 million, or 1%, in 2019 as compared to 2018. As a percentage of revenue, sales and marketing expense decreased by approximately two percentage points, resulting from the 2018 Reallocation, increased cost efficiency, and leverage realized from changes to our sales commission plans as we continued our efforts to strategically scale our sales teams and improve their productivity.
Sales and marketing expenses decreased $15.6 million, or 7%, in 2018 as compared to 2017. As a percentage of revenue, sales and marketing expense decreased by approximately eight percentage points, primarily resulting from a combination of increased cost efficiency, reduction in headcount as part of our restructuring activities, and leverage realized from changes to our sales commission plans as we continued our efforts to strategically scale our sales teams and improve their productivity.
Table:
 |  | Year Ended December 31, | 
 | 2019 | 2018 | 2017
 |  | (dollars in thousands) | 
Sales and marketing | $227,733 | $224,635 | $240,271
Percent of revenue | 39.5% | 41.8% | 49.9%


Question: What was the sales and marketing expense in 2018?
Answer: $224,635
table of contents the following table discloses purchases of shares of our common stock made by us or on our behalf during the fourth quarter of 2017 . period total number of shares purchased average price paid per share total number of shares not purchased as part of publicly announced plans or programs ( a ) total number of shares purchased as part of publicly announced plans or programs approximate dollar value of shares that may yet be purchased under the plans or programs ( b ) .

Table:
period | total numberof sharespurchased | averageprice paidper share | total number ofshares notpurchased as part ofpublicly announcedplans or programs ( a ) | total number ofshares purchased aspart of publiclyannounced plans orprograms | approximate dollarvalue of shares thatmay yet be purchasedunder the plans orprograms ( b )
october 2017 | 515762 | $ 77.15 | 292145 | 223617 | $ 1.6 billion
november 2017 | 2186889 | $ 81.21 | 216415 | 1970474 | $ 1.4 billion
december 2017 | 2330263 | $ 87.76 | 798 | 2329465 | $ 1.2 billion
total | 5032914 | $ 83.83 | 509358 | 4523556 | $ 1.2 billion
( a ) the shares reported in this column represent purchases settled in the fourth quarter of 2017 relating to ( i ) our purchases of shares in open-market transactions to meet our obligations under stock-based compensation plans , and ( ii ) our purchases of shares from our employees and non-employee directors in connection with the exercise of stock options , the vesting of restricted stock , and other stock compensation transactions in accordance with the terms of our stock-based compensation plans .
( b ) on september 21 , 2016 , we announced that our board of directors authorized our purchase of up to $ 2.5 billion of our outstanding common stock ( the 2016 program ) with no expiration date .
as of december 31 , 2017 , we had $ 1.2 billion remaining available for purchase under the 2016 program .
on january 23 , 2018 , we announced that our board of directors authorized our purchase of up to an additional $ 2.5 billion of our outstanding common stock with no expiration date. .

Question: for the fourth quarter of 2017 what was the percent of the total number of shares purchased in november
Answer: 43.5%
Calculation: divide(2186889, 5032914)
movement in exit cost liabilities the movement in exit cost liabilities for pmi was as follows : ( in millions ) .

Table:
liability balance january 1 2014 | $ 308
charges net | 391
cash spent | -360 ( 360 )
currency/other | -69 ( 69 )
liability balance december 31 2014 | $ 270
charges net | 68
cash spent | -232 ( 232 )
currency/other | -52 ( 52 )
liability balance december 31 2015 | $ 54
cash payments related to exit costs at pmi were $ 232 million , $ 360 million and $ 21 million for the years ended december 31 , 2015 , 2014 and 2013 , respectively .
future cash payments for exit costs incurred to date are expected to be approximately $ 54 million , and will be substantially paid by the end of 2017 .
the pre-tax asset impairment and exit costs shown above are primarily a result of the following : the netherlands on april 4 , 2014 , pmi announced the initiation by its affiliate , philip morris holland b.v .
( 201cpmh 201d ) , of consultations with employee representatives on a proposal to discontinue cigarette production at its factory located in bergen op zoom , the netherlands .
pmh reached an agreement with the trade unions and their members on a social plan and ceased cigarette production on september 1 , 2014 .
during 2014 , total pre-tax asset impairment and exit costs of $ 489 million were recorded for this program in the european union segment .
this amount includes employee separation costs of $ 343 million , asset impairment costs of $ 139 million and other separation costs of $ 7 million .
separation program charges pmi recorded other pre-tax separation program charges of $ 68 million , $ 41 million and $ 51 million for the years ended december 31 , 2015 , 2014 and 2013 , respectively .
the 2015 other pre-tax separation program charges primarily related to severance costs for the organizational restructuring in the european union segment .
the 2014 other pre-tax separation program charges primarily related to severance costs for factory closures in australia and canada and the restructuring of the u.s .
leaf purchasing model .
the 2013 pre-tax separation program charges primarily related to the restructuring of global and regional functions based in switzerland and australia .
contract termination charges during 2013 , pmi recorded exit costs of $ 258 million related to the termination of distribution agreements in eastern europe , middle east & africa ( due to a new business model in egypt ) and asia .
asset impairment charges during 2014 , pmi recorded other pre-tax asset impairment charges of $ 5 million related to a factory closure in canada. .

Question: what is the change in liability balance during 2014?
Answer: 38
Calculation: subtract(270, 308)
Thomas Clark
(1) Represents accelerated vesting of 33,711 stock options. Pursuant to Mr. Clark’s stock option agreements (dated January 17, 2019), if Mr. Clark’s employment is terminated without cause or for good reason within six months following a “change in control”, he will become immediately vested in all outstanding unvested stock options, and all of Mr. Clark’s outstanding options shall remain exercisable in accordance with their terms, but in no event for less than 90 days after such termination. (1) Represents accelerated vesting of 33,711 stock options. Pursuant to Mr. Clark’s stock option agreements (dated January 17, 2019), if Mr. Clark’s employment is terminated without cause or for good reason within six months following a “change in control”, he will become immediately vested in all outstanding unvested stock options, and all of Mr. Clark’s outstanding options shall remain exercisable in accordance with their terms, but in no event for less than 90 days after such termination. (1) Represents accelerated vesting of 33,711 stock options. Pursuant to Mr. Clark’s stock option agreements (dated January 17, 2019), if Mr. Clark’s employment is terminated without cause or for good reason within six months following a “change in control”, he will become immediately vested in all outstanding unvested stock options, and all of Mr. Clark’s outstanding options shall remain exercisable in accordance with their terms, but in no event for less than 90 days after such termination.
(2) Represents accelerated vesting of 8,340 unvested performance restricted stock units. Pursuant to Mr. Clark’s performance restricted stock unit agreement (dated January 17, 2019), if Mr. Clark’s employment is terminated without cause or for good reason within six months following a “change in control” or if Mr. Clark's employment is terminated due to death or total disability, all non-vested units shall accelerate and be vested as of the date of termination.
Table:
Type of Payment | Termination by Systemax without “Cause” or Resignation by Employee for “good reason” ($) | Termination Due to Death or Total Disability ($) | Change In Control Only ($) | Termination by Systemax without “Cause” or Resignation by Employee for “good reason” within a certain period of time following a Change in Control ($)
Cash Compensation (Salary & Non-Equity Incentive Compensation) | - | - | - | -
Value of Accelerated Vesting of Stock Option Awards | - | - | - | 314,100 (1)
Value of Accelerated Vesting of Restricted Stock Unit Awards | - | - | - | -
Value of Accelerated Vesting of Performance Restricted Stock Unit Awards | - | 209,800 (2) | - | 209,800 (2)
Medical and Other Benefits | - | - | - | -
Total | - | 209,800 | - | 523,900


Question: What is the total termination due to Thomas Clark as a result of death or termination by Systemax without cause respectively?
Answer: 209,800, 523,900
5. Accrued expenses
Accrued expenses consisted of the following:
Table:
October 31, |  | 
 | 2019 | 2018
(In thousands) |  | 
Workers’ compensation claims | $9,687 | $9,020
Accrued wages | 19,525 | 14,142
Accrued rebates | 13,529 | 7,828
Accrued vacation  | 10,592 | 8,554
Accrued property taxes  | 11,331 | 9,453
Accrued payroll taxes | 8,290 | 9,034
Other accrued expenses  | 9,986 | 11,922
Total accrued expenses | $82,940 | $69,953


Question: What is the average Accrued payroll taxes for fiscal years 2019 and 2018?
Answer: 8662
Calculation: (8,290+ 9,034)/2
Our 2019 net revenues decreased 1.1% compared to the prior year, primarily due to a decrease in volumes of approximately 8%, partially compensated by an increase in average selling prices of approximately 7%. The increase in the average selling prices was driven by favorable product mix of approximately 10%, partially offset by a negative pricing effect of approximately 3%.
Our 2018 net revenues increased 15.8% compared to the prior year, primarily due to increase in average selling prices of approximately 16%, while volumes remained substantially flat. The increase in the average selling prices was driven by favorable product mix of approximately 18%, partially offset by a negative pricing effect of approximately 2%. Our net revenues registered double-digit growth across all product groups and geographies.
In 2019, 2018 and 2017, our largest customer, Apple, accounted for 17.6%, 13.1% and 10.5% of our net revenues, respectively, reported within our three product groups.
Table:
 | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | % Variation | % Variation
 | 2019 | 2018 | 2017 | 2019 vs 2018 | 2018 vs 2017
 | (in millions) | (in millions) | (in millions) |  | 
Net sales | $9,529 | $9,612 | $8,308 | (0.9)% | 15.7%
Other revenues | 27 | 52 | 39 | (49.0) | 36.1
Net revenues | $9,556 | $9,664 | $8,347 | (1.1)% | 15.8%


Question: What are the average Net revenues?
Answer: 9189
Calculation: (9,556+9,664+8,347 ) / 3